Effects of Intranasal Administrations of Oxytocin on Behavioural Troubles, Hyperphagia and Social Skills in Children With Prader-Willi Syndrome Aged From 3 to 12 Years.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Oxytocin (Primary)
- Indications Behavioural disorders
- Focus Therapeutic Use
- Acronyms Oxyjeune
- 02 Feb 2019 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 18 Apr 2017 New trial record